Thyroid cartilage Cricdd cartilage Tracheal Left upper Right Left Right Horizontal fissure ight Otliquc frsst_re loaer. 

Scene 1

Thyroid cartilage
Cricdd cartilage
Tracheal
Left upper
Right
Left
Right
Horizontal fissure
ight
Otliquc
frsst_re
loaer

Parenchyma of lungs is formed by respiratory unit that forms the terminal portion of respiratory tract. Respiratory unit is defined as the structural and functional unit of lung. Exchange of gases occurs only in this part of the respiratory tract.. 

Scene 2

Parenchyma of lungs is formed by respiratory unit that forms the terminal portion of respiratory tract. Respiratory unit is defined as the structural and functional unit of lung. Exchange of gases occurs only in this part of the respiratory tract.

Respiratory unit starts from the respiratory bronchioles . Each respiratory bronchiole divides into alveolar ducts. Each alveolar duct enters an enlarged structure called the alveolar sac. Space inside the alveolar sac is called antrum. Alveolar sac consists of a cluster of alveoli. Few alveoli are present in the wall of alveolar duct also. Thus, respiratory unit includes:. 

Scene 3

Respiratory unit starts from the respiratory bronchioles . Each respiratory bronchiole divides into alveolar ducts. Each alveolar duct enters an enlarged structure called the alveolar sac. Space inside the alveolar sac is called antrum. Alveolar sac consists of a cluster of alveoli. Few alveoli are present in the wall of alveolar duct also. Thus, respiratory unit includes:

Each alveolus is like a pouch with the diameter of about 0.2 to 0.5 mm. It is lined by epithelial cells

Capillary beds Connective tissue Alveolar d Mucous gland Mucosal linin monary vein Pulmonary artery Alveoli Atrium. 

Scene 4

Capillary beds
Connective tissue
Alveolar d
Mucous gland
Mucosal linin
monary vein
Pulmonary artery
Alveoli
Atrium

Pulmonary alveoli
Bronchioles
Alveoli
Alveolar duct
Alveolar sac
I Q ad frcg-n
Dreamstune.com

blood low in oxygen,
high in C02
C02 diffuses from
blood to be exhaled
Red blood Cells
Air moves in and out
of alveolus
0
Gases dissolve in
moist mucus lining
blood low in C02
high in Oxygen
Capillary wall
Alveolus wall
Oxygen diffuses
into blood
Oxygen is transported
around body by red
blood cells

Alveolar epithelium consists of alveolar cells or pneumocytes, which are of two types namely type I alveolar cells and type II alveolar cells.. 

Scene 5

Alveolar epithelium consists of alveolar cells or pneumocytes, which are of two types namely type I alveolar cells and type II alveolar cells.

Type I alveolar cells are the squamous epithelial cells  forming about 95% of the total number of cells. These cells  form the site of gaseous exchange between the alveolus  and blood.

Type II alveolar cells are cuboidal in nature and form about 5% of alveolar cells. These cells are also called granular pneumocytes.

Type II alveolar cells secrete alveolar fluid and surfactant.

Alveolar type II cell Lamellar body Tubular myelin Alveolar fluid Alveolar macrophage Alveolar type I cell Surfactant layer Air space. 

Scene 6

Symmetry | Free Full-Text | Simulated Breathing: Application of Molecular  Dynamics Simulations to Pulmonary Lung Surfactant

Alveolar type II cell
Lamellar body
Tubular myelin
Alveolar fluid
Alveolar macrophage
Alveolar type I cell
Surfactant layer
Air space

Due to intermolecular force of attraction between the water molecules, Water molecules come closer.. 

Scene 7

Due to intermolecular force of attraction between the water molecules, Water molecules come closer.

Water molecules in the deeper layer are attracted equally  from all the sides but not from the surface as air is present on the surface.

Water molecules do not interact with Air molecules which is a reason for surface tension.

Water molecules tend to shrink to bottom and this causes collapse of alveoli and air moves out.

SURFACE TENSION is the force exerted by water molecules on the surface of lung tissue.

When the water surface attempting to contract, it tends to move air out of the alveoli and cause collapse of alveoli.

Surface tension tends to collapse the alveoli, but this is countered by a kind of "coating" that covers the alveolar surface called surfactant. Surfactant reduces the surface tension of water, keeping the alveoli open so that we can breathe easily.

It pulls water in the blood like the vacuum. Pulmonary Edema. 

Scene 8

It pulls water in the blood like the vacuum

Thickness of respiratory membrane increases

LAW OF LAPLACE. It applies to bubbles of unequal radius attached to a Y-tube. The pressure (P) in a bubble is equal to 4 times the surface tension (T) divided by the radius (r). As applied to the grape-like alveolus, where only the inner wall has a liquid surface exposed to gas, the formula is P = 2T/r. The pressure difference between the inside and the outside of an elastic sphere ("Laplace pressure") is inversely proportional to the radius and directly proportional to the surface tension. P= 2T/r where, P= Collapsing pressure T= Surface tension r = Radius. 

Scene 9

It applies to bubbles of unequal radius attached to a Y-tube. The pressure (P) in a bubble is equal to 4 times the surface tension (T) divided by the radius (r). As applied to the grape-like alveolus, where only the inner wall has a liquid surface exposed to gas, the formula is P = 2T/r. The pressure difference between the inside and the outside of an elastic sphere ("Laplace pressure") is inversely proportional to the radius and directly proportional to the surface tension.                                                                       P= 2T/r       where,        P= Collapsing pressure        T= Surface tension        r = Radius

Laplace's Law: 2y/r API = Air Hypo phase. LAPLACE'S LAW P = 50 Alveolus B Alveolus A 2T 2 x 50 2 r=2 P (Pressure) 2T 2 x 50 1 p 100 https://bodvtomv.com/lung-compliance-explained. 

Scene 10

Laplace's Law:
2y/r
API =
Air
Hypo phase

LAPLACE'S LAW
P = 50
Alveolus B
Alveolus A
2T
2 x 50
2
r=2
P (Pressure)
2T
2 x 50
1
p 100
https://bodvtomv.com/lung-compliance-explained

Consequences of LAPLACE LAW. Smaller partially deflated alveoli will have lower compliance and higher Laplace pressure at any given surface tension. Increased Laplace pressure upon small alveoli promotes their collapse, as they empty into neighbouring larger alveoli. Alveolar surface tension adds to the pulmonary capillary hydrostatic gradient (i.e. it promotes the ultrafiltration of oedema fluid). When the surface tension increases (or radius is small), the collapsing pressure increases and alveoli will collapse. When the surface tension decreases, the collapsing pressure decreases.. 

Scene 11

Smaller partially deflated alveoli will have lower compliance and higher Laplace pressure at any given surface tension. Increased Laplace pressure upon small alveoli promotes their collapse, as they empty into  neighbouring  larger alveoli. Alveolar surface tension adds to the pulmonary capillary hydrostatic gradient (i.e. it promotes the  ultrafiltration  of  oedema  fluid). When the surface tension increases (or radius is small), the collapsing pressure increases and alveoli will collapse. When the surface tension decreases, the collapsing pressure decreases.

COLLAPSING TENDENCY OF LUNGS. Lungs are under constant threat to collapse even in resting conditions because of certain factors. Two factors are responsible for the collapsing tendency of lungs: 1. Elastic property of lung tissues: Elastic tissues of lungs show constant recoiling tendency and try to collapse the lungs 2. Surface tension: It is the tension exerted by the fluid secreted from alveolar epithelium on the surface of alveolar membrane. Fortunately, there are some factors, which save the lungs from collapsing.. 

Scene 12

Lungs are under constant threat to collapse even in resting conditions because of certain factors. Two factors are responsible for the collapsing tendency of lungs:  1. Elastic property of lung tissues: Elastic tissues of lungs show constant recoiling tendency and try to collapse the lungs  2. Surface tension: It is the tension exerted by the fluid secreted from alveolar epithelium on the surface of alveolar membrane. Fortunately, there are some factors, which save the lungs from collapsing.

In spite of elastic property of lungs and surface tension in the alveoli of lungs, the collapsing tendency of lungs is prevented by two factors:. 

Scene 13

FACTORS PREVENTING COLLAPSING TENDENCY OF LUNGS

In spite of elastic property of lungs and surface tension in the alveoli of lungs, the collapsing tendency of lungs is prevented by two factors:

It is a surface acting material or agent that is responsible for lowering the surface tension of a fluid.. 

Scene 14

It is a surface acting material or agent that is responsible for lowering the surface tension of a fluid.

Source of secretion of pulmonary surfactant

Pulmonary surfactant is secreted by two types of cells:

1. Type II alveolar epithelial cells in the lungs, which are called surfactant secreting alveolar cells or pneumocytes.

Characteristic feature of these cells is the presence of microvilli on their alveolar surface.

2. Clara cells, which are situated in the bronchioles. These cells are also called bronchiolar exocrine cells.

Atmospheric pressure Transpulmonary pressure: 760 mm Hg —756 mm Hg = 4 mm Hg Intrapleural pressure: 756 mm Hg (—4 mm Hg) Intra-alveolar pressure: 760 mm Hg (O mm Hg) Parietal pleura Visceral pleura Pleural cavity Thoracic wall Lung Diaphragm. 

Scene 15

Atmospheric pressure
Transpulmonary pressure:
760 mm Hg —756 mm Hg
= 4 mm Hg
Intrapleural pressure:
756 mm Hg (—4 mm Hg)
Intra-alveolar pressure:
760 mm Hg (O mm Hg)
Parietal pleura
Visceral pleura
Pleural cavity
Thoracic wall
Lung
Diaphragm

Clara cells in epith. Of
respiratory bronchiole.
(Note vesicles in cytoplasm)
Clara cells

Surfactant is a lipoprotein complex formed by lipids especially phospholipids, proteins and ions. 

Scene 16

Surfactant is a lipoprotein complex formed by lipids especially phospholipids, proteins and ions

1. Phospholipids: Phospholipids form about 75% of the surfactant. Major phospholipid present in the surfactant is dipalmitoylphosphatidylcholine (DPPC).

2. Other lipids: Other lipid substances of surfactant are triglycerides and phosphatidylglycerol (PG).

3. Proteins: Proteins of the surfactant are called specific surfactant proteins. There are four main surfactant proteins, called SP­A, SP­B, SP­C and SP­D. SP­A and SP­D are hydrophilic, while SP­B and SP­C are hydrophobic.

Surfactant proteins are vital components of surfactant and the surfactant becomes inactive in the absence of proteins.

4. Ions: Ions present in the surfactant are mostly calcium ions.

Unsaturated PC Other 92% LIPIDS Chol Other 57. sp-A SP-D SP-B sp-c 8% PROTEINS. 

Scene 17

Unsaturated PC
Other
92%
LIPIDS
Chol
Other
57.
sp-A
SP-D
SP-B
sp-c
8%
PROTEINS

BILAYERS
SP-B
sp—A
content leakage
SP-B
aggregation
lipid exchange
(hemifusion )
content mixing
(fusion)
SP-B
liquid ordered
liquid disordered
liquid condensed
liquid expanded
INTERFACIAL FILMS
SP-B
SP-A
liquid ordered

FORMATION OF SURFACTANT. Type II alveolar epithelial cells and Clara cells have a special type of membrane bound organelles called lamellar bodies, which form the intracellular source of surfactant. Laminar bodies contain surfactant phospholipids and surfactant proteins. These materials are synthesized in endoplasmic reticulum and stored in laminar bodies. By means of exocytosis , lipids and proteins of lamellar bodies are released into surface fluid lining the alveoli. Here, in the presence of surfactant proteins and calcium, the phospholipids are arranged into a lattice (meshwork) structure called tubular myelin. Tubular myelin is in turn converted into surfactant in the form of a film that spreads over the entire surface of alveoli. Most of the surfactant is absorbed into the type II alveolar cells, catabolized and the products are loaded into lamellar bodies for recycling. 

Scene 18

Type II alveolar epithelial cells and Clara cells have a special type of membrane bound organelles called lamellar bodies, which form the intracellular source of surfactant. Laminar bodies contain surfactant phospholipids and surfactant proteins. These materials are synthesized in endoplasmic reticulum and stored in laminar bodies.        By means of  exocytosis , lipids and proteins of lamellar bodies are released into surface fluid lining the alveoli. Here, in the presence of surfactant proteins and calcium, the phospholipids are arranged into a lattice (meshwork) structure called tubular myelin. Tubular myelin is in turn converted into surfactant in the form of a film that spreads over the entire surface of alveoli.       Most of the surfactant is absorbed into the type II alveolar cells,  catabolized  and the products are loaded into lamellar bodies for recycling

Factors necessary for the formation and spreading of surfactant. 

Scene 19

Factors necessary for the formation and spreading of surfactant

Formation of surfactant requires many substances. Formation of tubular myelin requires DPPC, PG and the hydrophobic proteins, SP­B and SP­C. Formation of surfactant film requires SP­B, SP­C and PG.      Type II alveolar epithelial cells occupy only about 5% of alveolar surface. However, the surfactant must spread over the entire alveolar surface. It is facilitated by PG and calcium ions.       Glucocorticoids  play important role in the formation of surfactant .

Relation between surface tension and surfactant. It lowers the surface tension of fluid lining the lining the alveoli. Surface tension is inversely proportional to surfactant concentration. During inspiration surfactant molecules move apart as lungs are expanded and during expiration surfactant molecules become concentrated as lungs shorten. When there is no surfactant, surface tension is 50 dynes/cm. When surfactant is present it is 5-30 dynes/cm depending upon the concentration .. 

Scene 20

Relation between surface tension and surfactant

It lowers the surface tension of fluid lining the lining the alveoli. Surface tension is inversely proportional to surfactant concentration. During inspiration surfactant molecules move apart as lungs are expanded and during expiration surfactant molecules become concentrated as lungs shorten. When there is no surfactant, surface tension is 50 dynes/cm. When surfactant is present it is 5-30 dynes/cm depending upon the concentration .

FUNCTIONS OF SURFACTANT. Surfactant reduces the surface tension in the alveoli of lungs and prevents collapsing tendency of lungs. Surfactant acts by the following mechanism: Phospholipid molecule in the surfactant has two portions. One portion of the molecule is hydrophilic. This portion dissolves in water and lines the alveoli. Other portion is hydrophobic and it is directed towards the alveolar air. This surface of the phospholipid along with other portion spreads over the alveoli and reduces the surface tension. SP­B and SP­C play active role in this process.. 

Scene 21

Surfactant reduces the surface tension in the alveoli of lungs and prevents collapsing tendency of lungs. Surfactant acts by the following mechanism:  Phospholipid  molecule in the surfactant has two portions. One portion of the molecule is hydrophilic. This portion dissolves in water and lines the alveoli. Other portion is hydrophobic and it is directed towards the alveolar air. This surface of the  phospholipid  along with other portion spreads over the alveoli and reduces the surface tension. SP­B and SP­C play active role in this process.

Surfactant is responsible for stabilization of the alveoli, which is necessary to withstand the collapsing tendency. It plays an important role in the inflation of lungs after birth. In fetus, the secretion of surfactant begins after the 3rd month. Until birth, the lungs are solid and not expanded. Soon after birth, the first breath starts because of the stimulation of respiratory centers by hypoxia and hypercapnea . Although the respiratory movements are attempted by the infant, the lungs tend to collapse repeatedly. And, the presence of surfactant in the alveoli prevents the lungs from collapsing. Another important function of surfactant is its role in defense within the lungs against infection and inflammation. Hydrophilic proteins SP­A and SP­D destroy the bacteria and viruses by means of opsoni za tion . These two proteins also control the formation of inflammatory mediators .. 

Scene 22

Surfactant is responsible for stabilization of the alveoli, which is necessary to withstand the collapsing tendency.   It plays an important role in the inflation of lungs after birth. In fetus, the secretion of surfactant begins after the 3rd month. Until birth, the lungs are solid and not expanded. Soon after birth, the first breath starts because of the stimulation of respiratory centers by hypoxia and  hypercapnea . Although the respiratory movements are attempted by the infant, the lungs tend to collapse repeatedly. And, the presence of surfactant in the alveoli prevents the lungs from collapsing.   Another important function of surfactant is its role in defense within the lungs against infection and inflammation. Hydrophilic proteins SP­A and SP­D destroy the bacteria and viruses by means of  opsoni   za   tion . These two proteins also control the formation of inflammatory mediators .

EFFECT OF DEFICIENCY OF SURFACTANT. Absence of surfactant in infants, causes collapse of lungs and the condition is called respiratory distress syndrome or hyaline membrane disease . Deficiency of surfactant occurs in adults also and it is called adult respiratory distress syndrome (ARDS). In addition, the deficiency of surfactant increases the susceptibility for bacterial and viral infections. 

Scene 23

Absence of surfactant in infants, causes collapse of lungs and the condition is called  respiratory distress syndrome  or  hyaline membrane disease . Deficiency of surfactant occurs in adults also and it is called  adult respiratory distress syndrome (ARDS).     In addition, the deficiency of surfactant increases the susceptibility for bacterial and viral infections

HYALINE MEMBRANE DISEASE. Hyaline membrane disease (HMD), also called respiratory distress syndrome (RDS), is a condition that causes babies to need extra oxygen and help breathing. HMD is one of the most common problems seen in premature babies . The more premature the baby, the higher the risk and the more severe the HMD. HMD typically worsens over the first 48 to 72 hours and then improves with treatment. More than 90 percent of babies with HMD survive.. 

Scene 24

Hyaline membrane disease  (HMD), also called respiratory distress syndrome (RDS), is a condition that causes babies to need extra oxygen and help breathing. HMD is one of the  most common problems  seen in  premature babies . The more premature the baby, the higher the risk and the more severe the HMD. HMD typically worsens over the first 48 to 72 hours and then improves with treatment. More than 90 percent of babies with HMD survive.

DIAGNOSIS. HMD is usually diagnosed by a combination of assessments, including: appearance, color, and breathing efforts (these signs indicate your baby's need for oxygen) x-rays of lungs : x-rays are electromagnetic energy used to produce images of bones and internal organs onto film. In HMD, they often show a unique “ground glass” appearance called a reticulogranular pattern. blood gasses (tests for oxygen, carbon dioxide, and acid in arterial blood): often show lowered amounts of oxygen and increased carbon dioxide. echocardiography (EKG) : may be used to rule out heart problems that could cause symptoms similar to HMD. An electrocardiogram is a test that records the electrical activity of the heart, shows arrhythmias (abnormal rhythms), and detects damage to the heart muscle.. 

Scene 25

HMD is usually diagnosed by a combination of assessments, including: appearance, color, and breathing efforts  (these signs indicate your baby's need for oxygen) x-rays  of lungs : x-rays are electromagnetic energy used to produce images of bones and internal organs onto film. In HMD, they often show a unique “ground glass” appearance called a reticulogranular pattern. blood gasses  (tests for oxygen, carbon dioxide, and acid in arterial blood): often show lowered amounts of oxygen and increased carbon dioxide. echocardiography (EKG) : may be used to rule out heart problems that could cause symptoms similar to HMD. An  electrocardiogram  is a test that records the electrical activity of the heart, shows  arrhythmias  (abnormal rhythms), and detects damage to the heart muscle.

HMD occurs when there is not enough of a substance in the lungs called surfactant. Surfactant is made by the cells in the airways and consists of phospholipids and protein. It begins to be produced in the fetus at about 24 to 28 weeks of pregnancy , and is found in amniotic fluid between 28 and 32 weeks. By about 35 weeks gestation, most babies have developed adequate amounts of surfactant.. 

Scene 26

HMD  occurs when there is not enough of a substance in the lungs called surfactant. Surfactant is made by the cells in the airways and consists of phospholipids and protein. It begins to be produced in the fetus at about  24 to 28 weeks of pregnancy , and is found in amniotic fluid between 28 and 32 weeks. By about 35 weeks gestation, most babies have developed adequate amounts of surfactant.

Normal Hyaline membrane. Infant Respiratory Distress Syndrome Newborn After Healthy Delivery O, o. o, o. O, the Respiratory Distress Following Premature Delivery diminist•s •suit"" in de.t'. Oxygen and dioxi& respiration. Oxygen. 

Scene 27

Infant Respiratory Distress Syndrome
Newborn After
Healthy Delivery
O,
o.
o,
o.
O,
the
Respiratory Distress
Following Premature
Delivery
diminist•s
•suit"" in
de.t'.
Oxygen and dioxi&
respiration.
Oxygen

TREATMENT. Treatment for HMD may include : placing an endotracheal tube (breathing tube, also called an ET) into baby's windpipe mechanical breathing machine (to do the work of breathing for baby ) supplemental oxygen (extra amounts of oxygen) continuous positive airway pressure (CPAP): a mechanical breathing machine that pushes a continuous flow of air or oxygen to the airways to help keep tiny air passages in the lungs open. surfactant replacement with artificial surfactant : this treatment has been shown to reduce the severity of HMD, and is most effective if started in the first six hours of birth. It may be given as preventive treatment for babies at very high risk for HMD, or used as a “rescue” method. The drug comes as a powder that is mixed with sterile water and given through the ET tube. This treatment is usually administered in several doses. medications (to help sedate and ease baby's pain during treatment). 

Scene 28

Treatment  for HMD may include :     placing  an  endotracheal  tube  (breathing tube, also called an ET) into    baby's windpipe     mechanical  breathing machine  (to do the work of breathing  for baby )     supplemental  oxygen  (extra amounts of oxygen)     continuous  positive airway pressure  (CPAP): a mechanical breathing machine that pushes a continuous flow of air or oxygen to the airways to help keep tiny air passages in the lungs  open.     surfactant  replacement with artificial surfactant : this treatment has been shown to reduce the severity of HMD, and is most effective if started in the first six hours of birth. It may be given as preventive treatment for babies at very high risk for HMD, or used as a “rescue” method. The drug comes as a powder that is mixed with sterile water and given through the ET tube. This treatment is usually administered in several doses.     medications  (to help sedate and  ease baby's  pain during treatment)

ACUTE RESPIRATORY DISTRESS SYNDROME. Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function. ARDS typically occurs in people who are already critically ill or who have significant injuries. Severe shortness of breath — the main symptom of ARDS — usually develops within a few hours to a few days after the precipitating injury or infection. Many people who develop ARDS don't survive. The risk of death increases with age and severity of illness. Of the people who do survive ARDS, some recover completely while others experience lasting damage to their lungs.. 

Scene 29

Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function. ARDS typically occurs in people who are already critically ill or who have significant injuries. Severe shortness of breath — the main symptom of ARDS — usually develops within a few hours to a few days after the precipitating injury or infection. Many people who develop ARDS don't survive. The risk of death increases with age and severity of illness. Of the people who do survive ARDS, some recover completely while others experience lasting damage to their lungs.

SYMPTOMS. The signs and symptoms of ARDS can vary in intensity, depending on its cause and severity, as well as the presence of underlying heart or lung disease. They include : Severe shortness of breath or breathlessness. Rapid and labored breathing. Extreme tiredness and muscle fatigue. Confusion . Rapid heart rate. Bluish color of fingernails and lips due to low oxygen level in the blood. Cough and chest pain. If ARDS is caused by severe infection (sepsis), symptoms of sepsis may also be present ( fever , low blood pressure).. 

Scene 30

The  signs and symptoms of ARDS can vary in intensity, depending on its cause and severity, as well as the presence of underlying heart or lung disease. They include :        Severe  shortness of breath or breathlessness.        Rapid  and labored breathing.        Extreme  tiredness and muscle fatigue.        Confusion .        Rapid  heart rate.        Bluish  color of fingernails and lips due to low oxygen level in the blood.        Cough  and chest pain.        If  ARDS is caused by severe infection (sepsis), symptoms of sepsis may also be present ( fever , low blood pressure).

CAUSES. The mechanical cause of ARDS is fluid leaked from the smallest blood vessels in the lungs into the tiny air sacs where blood is oxygenated. Normally, a protective membrane keeps this fluid in the vessels. Severe illness or injury, however, can cause damage to the membrane, leading to the fluid leakage of ARDS . Underlying causes of ARDS include: Sepsis. The most common cause of ARDS is sepsis, a serious and widespread infection of the bloodstream. Inhalation of harmful substances. Breathing high concentrations of smoke or chemical fumes can result in ARDS, as can inhaling (aspirating) vomit or near-drowning episodes. Severe pneumonia. Severe cases of pneumonia usually affect all five lobes of the lungs. Head, chest or other major injury. Accidents, such as falls or car crashes, can directly damage the lungs or the portion of the brain that controls breathing. Coronavirus disease 2019 (COVID-19). People who have severe COVID-19 may develop ARDS. Others. Pancreatitis (inflammation of the pancreas), massive blood transfusions and burns.. 

Scene 31

The  mechanical cause of ARDS is fluid leaked from the smallest blood vessels in the lungs into the tiny air sacs where blood is oxygenated. Normally, a protective membrane keeps this fluid in the vessels. Severe illness or injury, however, can cause damage to the membrane, leading to the fluid leakage of ARDS .           Underlying  causes of ARDS include: Sepsis.  The most common cause of ARDS is sepsis, a serious and widespread infection of the bloodstream. Inhalation of harmful substances.  Breathing high concentrations of smoke or chemical fumes can result in ARDS, as can inhaling (aspirating) vomit or near-drowning episodes. Severe pneumonia.  Severe cases of pneumonia usually affect all five lobes of the lungs. Head, chest or other major injury.  Accidents, such as falls or car crashes, can directly damage the lungs or the portion of the brain that controls breathing. Coronavirus  disease 2019 (COVID-19).  People who have severe COVID-19 may develop ARDS. Others.  Pancreatitis (inflammation of the pancreas), massive blood transfusions and burns.

Treated I Normal lung lung surfactant produced by type II alveolar cells destruction of I type II alveolar cells activation of tissue macrophages Cytokine 1 secretion COVID-19 associated ARDS massive macropage infiltration Alveolar macrophage ctivation Cyto ine „storm" (IL-6, TNFc) destruction of type II alveolar cells vere loss of anti- inflammatory lung protective surfactant lung surfactant. 

Scene 32

Treated I Normal lung
lung surfactant produced by
type II alveolar cells
destruction of I
type II alveolar
cells
activation of
tissue
macrophages
Cytokine
1
secretion
COVID-19 associated ARDS
massive macropage
infiltration
Alveolar macrophage
ctivation
Cyto ine „storm"
(IL-6, TNFc)
destruction of type II
alveolar cells
vere loss of anti-
inflammatory lung
protective surfactant
lung surfactant

Acute Respiratory
Distress Syndrome
(ARDS)
o
Healthy
alveoli
ST VINCEN
LUNG HEALT
Thickening of the walls
and fluid inside the alveoli
nts gas exchange
Alveoli with
ARDS

DIAGNOSIS. When symptoms of ARDS occur, a combinations of tests may be done: Chest X-ray to measure fluids in the lungs. A blood test to determine oxygen level in the blood to help determine the severity of ARDS. Echocardiogram (ultrasound of the heart) to evaluate heart function. 

Scene 33

When  symptoms of ARDS occur, a combinations of tests may be done: Chest X-ray  to measure fluids in the lungs. A blood test to determine oxygen level in the blood to help determine the severity of ARDS. Echocardiogram  (ultrasound of the heart) to evaluate heart  function

TREATMENT. ARDS is usually treated in the intensive care unit (ICU) along with treatment of the underlying cause. Mechanical ventilation (a ventilator) is often used in caring for patients with ARDS. For milder cases of ARDS, oxygen may be given through a fitted face mask or a cannula fitted over the nose. Steps to minimize complications from ARDS are commonly used. These include: Sedation to manage pain. Breathing tests to determine when it’s safe to remove the tube and ventilator. Blood thinners to prevent clots. Minimizing fluid buildup in the lungs. Minimizing stress ulcers in the stomach. Active mobility and physical therapy to prevent muscle weakness. No direct drug therapy has been shown to improve survival in ARDS, but researchers continue to work on finding treatment.. 

Scene 34

ARDS is usually treated in the intensive care unit (ICU) along with treatment of the underlying cause. Mechanical ventilation  (a ventilator) is often used in caring for patients with ARDS. For milder cases of ARDS, oxygen may be given through a fitted face mask or a  cannula  fitted over the nose. Steps to minimize complications  from ARDS are commonly used. These include: Sedation to manage pain. Breathing tests to determine when it’s safe to remove the tube and ventilator. Blood thinners to prevent clots. Minimizing fluid buildup in the lungs. Minimizing stress ulcers in the stomach. Active mobility and physical therapy to prevent muscle weakness.        No direct drug therapy has been shown to improve survival in ARDS, but researchers continue to work on finding treatment.

Scene 35

LUNG SURFACTANT

Scene 0

 Hyaline membrane disease  (HMD), also called respiratory distress syndrome (RDS), is a condition that causes babies to need extra oxygen and help breathing. HMD is one of the  most common problems  seen in  premature babies . The more premature the baby, the higher the risk and the more severe the HMD. HMD typically worsens over the first 48 to 72 hours and then improves with treatment. More than 90 percent of babies with HMD survive.

slide24-hotlink3

 HMD is usually diagnosed by a combination of assessments, including: appearance, color, and breathing efforts  (these signs indicate your baby's need for oxygen) x-rays  of lungs : x-rays are electromagnetic energy used to produce images of bones and internal organs onto film. In HMD, they often show a unique “ground glass” appearance called a reticulogranular pattern. blood gasses  (tests for oxygen, carbon dioxide, and acid in arterial blood): often show lowered amounts of oxygen and increased carbon dioxide. echocardiography (EKG) : may be used to rule out heart problems that could cause symptoms similar to HMD. An  electrocardiogram  is a test that records the electrical activity of the heart, shows  arrhythmias  (abnormal rhythms), and detects damage to the heart muscle.

slide25-hotlink3

        The  signs and symptoms of ARDS can vary in intensity, depending on its cause and severity, as well as the presence of underlying heart or lung disease. They include :        Severe  shortness of breath or breathlessness.        Rapid  and labored breathing.        Extreme  tiredness and muscle fatigue.        Confusion .        Rapid  heart rate.        Bluish  color of fingernails and lips due to low oxygen level in the blood.        Cough  and chest pain.        If  ARDS is caused by severe infection (sepsis), symptoms of sepsis may also be present ( fever , low blood pressure).

slide30-hotlink3

      When  symptoms of ARDS occur, a combinations of tests may be done: Chest X-ray  to measure fluids in the lungs. A blood test to determine oxygen level in the blood to help determine the severity of ARDS. Echocardiogram  (ultrasound of the heart) to evaluate heart  function

slide33-hotlink3

       ARDS is usually treated in the intensive care unit (ICU) along with treatment of the underlying cause. Mechanical ventilation  (a ventilator) is often used in caring for patients with ARDS. For milder cases of ARDS, oxygen may be given through a fitted face mask or a  cannula  fitted over the nose. Steps to minimize complications  from ARDS are commonly used. These include: Sedation to manage pain. Breathing tests to determine when it’s safe to remove the tube and ventilator. Blood thinners to prevent clots. Minimizing fluid buildup in the lungs. Minimizing stress ulcers in the stomach. Active mobility and physical therapy to prevent muscle weakness.        No direct drug therapy has been shown to improve survival in ARDS, but researchers continue to work on finding treatment.